Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD
- Conditions
- Posttraumatic Stress Disorder
- Interventions
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2023-07-12
- Target Recruit Count
- 80
- Registration Number
- NCT02759185
- Locations
- 🇺🇸
Scottsdale Research Institute, Phoenix, Arizona, United States
Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
- Locations
- 🇺🇸
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2023-07-12
- Target Recruit Count
- 12
- Registration Number
- NCT00920387
- Locations
- 🇨🇭
Private Practices of Peter Gasser MD, Solothurn, Switzerland
News
FDA Approves Cannabis Study for PTSD in Veterans, Potentially Boosting Cannabis Stocks
The FDA has approved a study examining cannabis's therapeutic effects on 320 veterans with moderate to severe PTSD, a condition affecting roughly 7% of U.S. veterans.
FDA Approves Landmark Cannabis Study for PTSD Treatment in Veterans
The FDA has approved a study examining cannabis's therapeutic potential for treating post-traumatic stress disorder (PTSD) in 320 veterans.
FDA Approves Phase 2 Clinical Trial of Smoked Marijuana for PTSD in Veterans
The FDA has approved a Phase 2 clinical trial to evaluate smoked marijuana for treating PTSD in veterans, funded by Michigan cannabis sales tax revenue.
FDA Clears Phase 2 Trial of Smoked Cannabis for PTSD in Veterans
The FDA has cleared a Phase 2 trial to evaluate smoked cannabis in 320 veterans with moderate-to-severe PTSD who have prior cannabis use.